| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2023 |
4
| D'Alessandro Danilo (CFO) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Paid exercise price by delivering 4,958 shares
@ $5.01, valued at
$24.8k
|
|
| 10/03/2023 |
4
| Richards Timothy T. (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 2,226 shares
@ $5.01, valued at
$11.2k
|
|
| 10/03/2023 |
4
| FLETCHER R JOHN (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 1,153 shares
@ $5.01, valued at
$5.8k
|
|
| 10/03/2023 |
4
| Girin Pascal E R (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 1,434 shares
@ $5.01, valued at
$7.2k
|
|
| 08/22/2023 |
4
| D'Alessandro Danilo (CFO) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Paid exercise price by delivering 1,166 shares
@ $5.34, valued at
$6.2k
|
|
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2023 |
4
| STIGALL L. JEREMY (GM, Biologics & Drug Delivery) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Paid exercise price by delivering 1,730 shares
@ $6.53, valued at
$11.3k
|
|
| 07/05/2023 |
4
| BURNETT JOSEPH MICHAEL (CEO and President) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 2,095 shares
@ $6.15, valued at
$12.9k
|
|
| 07/05/2023 |
4
| STIGALL L. JEREMY (GM, Biologics & Drug Delivery) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 2,682 shares
@ $6.15, valued at
$16.5k
|
|
| 07/05/2023 |
4
| SABRA MAZIN (COO) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 552 shares
@ $6.15, valued at
$3.4k
|
|
| 07/05/2023 |
4
| D'Alessandro Danilo (CFO) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 1,371 shares
@ $6.15, valued at
$8.4k
|
|
| 07/05/2023 |
4
| FLETCHER R JOHN (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 798 shares
@ $7.24, valued at
$5.8k
|
|
| 07/05/2023 |
4
| Richards Timothy T. (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 1,540 shares
@ $7.24, valued at
$11.1k
|
|
| 07/05/2023 |
4
| Girin Pascal E R (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 992 shares
@ $7.24, valued at
$7.2k
|
|
| 05/26/2023 |
4
| Girin Pascal E R (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 17,153 restricted stock units
@ $0 |
|
| 05/26/2023 |
4
| Richards Timothy T. (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 17,153 restricted stock units
@ $0 |
|
| 05/26/2023 |
4
| Klein Matthew B. (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 17,153 restricted stock units
@ $0 |
|
| 05/26/2023 |
4
| FLETCHER R JOHN (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 17,153 restricted stock units
@ $0 |
|
| 05/26/2023 |
4
| LIAU LINDA M. (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 17,153 restricted stock units
@ $0 |
|
| 05/26/2023 |
4
| FALLON LYNNETTE C (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 17,153 restricted stock units
@ $0 |
|
| 05/26/2023 |
4
| JOHNSON B KRISTINE (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 17,153 restricted stock units
@ $0 |
|
| 04/04/2023 |
4
| Richards Timothy T. (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 1,321 shares
@ $8.44, valued at
$11.1k
|
|
| 04/04/2023 |
4
| FLETCHER R JOHN (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 684 shares
@ $8.44, valued at
$5.8k
|
|
| 04/04/2023 |
4
| Girin Pascal E R (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 851 shares
@ $8.44, valued at
$7.2k
|
|
| 03/08/2023 |
4
| BURNETT JOSEPH MICHAEL (CEO and President) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 39,506 options to buy
@ $8.1, valued at
$320k
Granted 118,518 restricted stock units
@ $0 |
|
| 03/08/2023 |
4
| STIGALL L. JEREMY (GM, Biologics & Drug Delivery) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 14,814 options to buy
@ $8.1, valued at
$120k
Granted 44,444 restricted stock units
@ $0 |
|
| 03/08/2023 |
4
| D'Alessandro Danilo (CFO) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 15,637 options to buy
@ $8.1, valued at
$126.7k
Granted 46,913 restricted stock units
@ $0 |
|
| 03/08/2023 |
4
| SABRA MAZIN (COO) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 11,522 options to buy
@ $8.1, valued at
$93.3k
Granted 34,567 restricted stock units
@ $0 |
|
| 02/23/2023 |
4
| STIGALL L. JEREMY (GM, Biologics & Drug Delivery) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Paid exercise price by delivering 514 shares
@ $8.55, valued at
$4.4k
|
|
| 01/04/2023 |
4
| Richards Timothy T. (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 1,399 shares
@ $7.97, valued at
$11.2k
|
|
| 01/04/2023 |
4
| Girin Pascal E R (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 901 shares
@ $7.97, valued at
$7.2k
|
|
| 01/04/2023 |
4
| FLETCHER R JOHN (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 2,175 shares
@ $7.97, valued at
$17.3k
|
|
| 01/04/2023 |
4
| JOHNSON B KRISTINE (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 431 shares
@ $7.97, valued at
$3.4k
|
|
|